Form EFFECT Kezar Life Sciences,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 14, 2026 |
| Accession Number: | 0001140361-26-020547 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BankGPT Helps Accountants and Small Businesses Convert Bank Statements Into Structured Financial Data
- Teton Peak Capital: Advancing Long-Term Value Creation Through Disciplined Investment and Strategic Analysis
- Binance Coin Price Holds $717 as 72% of Top Traders Bet Long, While Buyers Rush Into Pepeto
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share